Contraceptions masculines non déférentielles : revue de la littérature

25 avril 2007

Auteurs : Eric Huyghe, Joe Nohra, Delphine Vezzosi, Antoine Bennet, Philippe Caron, Roger Mieusset, Louis Bujan, Pierre Plante
Référence : Prog Urol, 2007, 2, 17, 156-164


Le texte complet de cet article est disponible en PDF.
Cliquer ici pour le visualiser


Anderson R.A., Baird D.T. Male contraception Endocr. Rev. 2002 ;  23 : 735-762 [cross-ref]
Wagner L., Costa P. Contraception masculine Encyclopédie médico chirurgicale 1998 ; [738-A-12].
Huyghe E., Blanc A., Nohra J., Khedis M., Labarthe P., Rougé D., Plante P. Vasectomie et chirurgies contraceptives déférentielles: aspects legaux et techniques Prog. Urol. 2007 ;
McLure Z. Failure rates of contraceptive methods Fam. Plann. Inf. Serv. 1981 ;  1 : 59-61
Shain R.N., Perdue S.T., Piper J.M., holden A.E., Champion J.D., Newton E.R., Korte J.E. Behaviors changed by intervention are associated with reduced STD recurrence : the importance of context in measurement Sex. Transm. Dis. 2002 ;  29 : 520-529 [cross-ref]
Cramer D.W., Goldman M.B., Schiff I., Belisle S., Albrecht B., Stadel B., Gibson M., Wilson E., Stillman R., Thompson I. The relationship of tubal infertility to barrier method and oral contraceptive use Jama 1987 ;  257 : 2446-2450 [cross-ref]
Carey R.F., Lytle C.D., Cyr W.H. Implications of laboratory tests of condom integrity Sex Transm. Dis. 1999 ;  26 : 216-220 [cross-ref]
Minuk G.Y., Bohme C.E., Bowen T.J., Hoar D.I., Cassol S., Gill M.J., Clarke H.C. Efficacy of commercial condoms in the prevention of hepatitis B virus infection Gastroenterology 1987 ;  93 : 710-714
Lytle C.D., Carney P.G., Vohra S., Cyr W.H., Bockstahler L.E. Virus leakage through natural membrane condoms Sex Transm. Dis. 1990 ;  17 : 58-62 [cross-ref]
Frezieres R.G., Walsh T.L., Nelson A.L., Clark V.A., Coulson A.H. Breakage and acceptability of a polyurethane condom : a randomized, controlled study Fam. Plann. Perspect. 1998 ;  30 : 73-78
Frezieres R.G., Walsh T.L., Nelson A.L., Clark V.A., Coulson A.H. Evaluation of the efficacy of a polyurethane condom : results from a randomized, controlled clinical trial Fam. Plann. Perspect. 1999 ;  31 : 81-87 [cross-ref]
Goldman J.A., Dicker D., Feldberg D., Samuel N., Resnik R. Barrier contraception in the teenager : a comparison of four methods in adolescent girls Pediatr. Adolesc. Gynecol. 1985 ;  3 : 59-76
Fihn S.D., Boyko E.J., Normand E.H., Chen C.L., Grafton J.R., Hunt M., Yarbro P., Scholes D., Stergachis A. Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women Am. J. Epidemiol. 1996 ;  144 : 512-520 [cross-ref]
Warner D.L., Boles J., Goldsmith J., Hatcher R.A. Disclosure of condom breakage to sexual partners Jama 1997 ;  278 : 291-292 [cross-ref]
Gaither G.A., Rosenkranz R.R., Amato-Henderson S., Plaud J.J., Bigwood S.J. The effect of condoms in sexually explicit narratives on maie sexual arousal J. Sex. Marital. Ther. 1996 ;  22 : 103-109 [cross-ref]
Amory J.K., Bremner W. Endocrine regulation of testicular fonction in men : implications for contraceptive development Mol. Cell. Endocrinol. 2001 ;  182 : 175-179 [cross-ref]
Sheth A.R., Moodbidri S.B. Potential application of inhibin in male and female contraception Adv. Contracept 1986 ;  2 : 131-139 [cross-ref]
Swerdloff R.S., Steiner B.S., Bhasin S. Gonadotropin releasing hormone (GnRH) agonists in maie contraception Med. Biol. 1986 ;  63 : 218-224
Guérin J.F. Contraception masculine hormonale Andrologie 1996 ;  6 : 259-265
Waites G.M. Development of methods of male contraception : impact of the World Health Organization Task Force Fertil. Steril. 2003 ;  80 : 1-15 [cross-ref]
Heckel N.J. Production of oligospermia in a man by the use of testosterone propionate Proc. Soc. Exp. Biol. Med. 1939 ;  40 : 658-659 [cross-ref]
Fertility W.H.O.T.F.O.M.F.T.R.O.M Contraceptive efficacy of testosterone-induced azoospermia in normal men Lancet 1990 ;  336 : 955-959
Fertility W.H.O.T.F.O.M.F.T.R.O.M Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men Fertil Steril 1996 ;  65 : 821-829
Handelsman D.J., Farley T.M., Peregoudova A., Waites G.M. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility Fertil. Steril. 1995 ;  63 : 125-133
Handelsman D.J., Conway A.J., Boylan L.M. Suppression of human spermatogenesis by testosterone implants J. Clin. Endocrinol. Metab. 1992 ;  75 : 1326-1332 [cross-ref]
Amory J.K., Anawalt B.D., Blaskovich P.D., Gilchriest J., Nuwayser E.S., Matsumoto A.M. Testosterone release from a sub- cutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men J. Androl. 2002 ;  23 : 84-91
Gu Y.Q., Wang X.H., Xu D., Peng L., Cheng L.F., Huang M.K., Huang Z.J., Zhang G.Y. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men J. Clin. Endocrinol. Metab. 2003 ;  88 : 562-568 [cross-ref]
Behre H.M., Baus S., Kliesch S., Keck C., Simoni M., Nieschlag E. Potential of testosterone buciclate for male contraception : endocrine differences between responders and nonresponders J. Clin. Endocrinol. Metab. 1995 ;  80 : 2394-2403 [cross-ref]
Kamischke A., Heuermann T., Kruger K., Von Eckardstein S., Schellschmidt I., Rubig A., Nieschlag E. An effective hormonal maie contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations J. Clin. Endocrinol. Metab. 2002 ;  87 : 530-539 [cross-ref]
Kamischke A., Venherm S., Ploger D., Von Eckardstein S., Nieschlag E. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for maie contraception J. Clin. Endocrinol. Metab. 2001 ;  86 : 303-309 [cross-ref]
Shen Z.R., Zhu J.H., Ma Z., Wang F., Wang Z.Y. Preparation of bio degradable microspheres of testosterone with poly(D, L-lactide-co-glycolide) and test of drug release in vitro Artif Cells Blood Substit Immobil Biotechnol. 2000 ;  28 : 57-64 [cross-ref]
Sundaram K., Kumar N. 7alpha-methyl-19-nortestosterone (MENT) : the optimal androgen for male contraception and replacement therapy Int. J. Androl. 2000 ;  23 : 13-15 [cross-ref]
Shaneyfelt T., Husein R., Bubley G., Mantzoros C.S. Hormonal predictors of prostate cancer a meta-analysis J. Clin. Oncol. 2000 ;  18 : 847-853
Isidori A.M., Giannetta E., Pozza C., Bonifacio V., Isidori A. Androgens, cardiovascular disease and osteoporosis J. Endocrinol. Invest. 2005 ;  28 : 73-79
Liu P.Y., Swerdloff R.S., Christenson P.D., Handelsman D.J., Wang C. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception : an integrated analysis Lancet 2006 ;  367 : 1412-1420 [cross-ref]
Heller C.G., Moore D.J., Paulsen C.A., Nelson W.O., Laidlaw W.M. Effects of progesterone and synthetic progestins on the reproductive physiology of normal men Fed. Proc. 1959 ;  18 : 1057-1065
Gonzalo I.T., Swerdloff R.S., Nelson A.L., Clevenger B., Garcia R., Berman N., Wang C. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone J. Clin. Endocrinol. Metab. 2002 ;  87 : 3562-3572 [cross-ref]
Pollanen P., Nikkanen V., Huhtaniemi I. Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception Int. J. Androl. 2001 ;  24 : 369-380 [cross-ref]
Bebb R.A., Anawalt B.D., Christensen R.B., Paulsen C.A., Bremner W.J., Matsumoto A.M. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach J. Clin. Endocrinol. Metab. 1996 ;  81 : 757-762 [cross-ref]
Page S.T., Amory J.K., Anawalt B.D., Irwig M.S., Brocken-Brough A.T., Matsumoto A.M., Bremner W.J. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist J. Clin. Endocrinol. Metab. 2006 ;  91 : 4374-4380
Handelsman D.J., Conway A.J., Howe C.J., Turner L., Mackey M.A. Establishing the minimum effective dose and additive effects of dépôt progestin in suppression of human spermatogenesis by a testosterone depot J. Clin. Endocrinol. Metab. 1996 ;  81 : 4113-4121 [cross-ref]
Foegh M., Nicol K., Petersen L.B., Schou G. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men Contraception 1980 ;  21 : 631-640 [cross-ref]
Meriggiola M.C., Cerpolini S., Bremner W.J., Mbizvo M.T., Vogelsong K.M., Martorana G., Pelusi G. Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men Hum. Reprod. 2006 ;  21 : 2033-2040 [cross-ref]
Meriggiola M.C., Bremner W.J., Paulsen C.A., Valdiserri A., Incorvaia L., Motta R., Pavani A., Capelli M., Flamigni C. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive J. Clin. Endocrinol. Metab. 1996 ;  81 : 3018-3023 [cross-ref]
Bouchard P., Garcia E. Influence of testosterone substitution on sperm suppression by LHRH agonists Horm. Res. 1987 ;  28 : 175-180 [cross-ref]
Fraser H.M. GnRH analogues for contraception Br. Med. Bull. 1993 ;  49 : 62-72
Behre H.M., Nashan D., Hubert W., Nieschlag E. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of maie contraception J. Clin. Endocrinol. Metab. 1992 ;  74 : 84-90 [cross-ref]
Bagatell C.J., Matsumoto A.M., Christensen R.B., Rivier J.E., Bremner W.J. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens J. Clin. Endocrinol. Metab. 1993 ;  77 : 427-432 [cross-ref]
Behre H.M., Kliesch S., Lemcke B., Von Eckardstein S., Nieschlag E. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone Hum. Reprod. 2001 ;  16 : 2570-2577 [cross-ref]
Bouchard P. GnRH antagonists: present and future Ann. Urol. (Paris) 2005 ;  39 : 56-58 [inter-ref]
Matthiesson K.L., Amory J.K., Berger R., Ugoni A., McLachlan R.I., Bremner W.J. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropinreleasing hormone antagonist J. Clin. Endocrinol. Metab. 2005 ;  90 : 91-97
Handelsman D.J., Wishart S., Conway A.J. Oestradiol enhances testosterone-induced suppression of human spermatogenesis Hum. Reprod. 2000 ;  15 : 672-679 [cross-ref]
Mieusset R., Bujan L., Mansat A., Pontonnier F., Grandjean H. Effects of artificial cryptorchidism on sperm morphology Fertil. Steril. 1987 ;  47 : 150-155
Mieusset R., Grandjean H., Mansat A., Pontonnier F. Inhibiting effect of artificial cryptorchidism on spermatogenesis Fertil. Steril. 1985 ;  43 : 589-594
Shafik A. Contraceptive efficacy of polyester-induced azoospermia in normal men Contraception 1992 ;  45 : 439-451 [cross-ref]
Fahim M.S., Fahim Z., Der R., Hall D.G., Harman J. Heat in male contraception (hot water 60 degrees C, infrared, microwave, and ultrasound) Contraception 1975 ;  11 : 549-562 [cross-ref]
Kandeel F.R., Swerdloff R.S. Role of temperature in regulation of spermatogenesis and the use of heating as a method for contraception Fertil. Steril. 1988 ;  49 : 1-23
Mieusset R., Bujan L. Testicular heating and its possible contributions to male infertility: a review Int. J. Androl. 1995 ;  18 : 169-184 [cross-ref]
Mieusset R., Bujan L. The potential of mild testicular heating as a safe, effective and reversible contraceptive method for men Int. J. Androl. 1994 ;  17 : 186-191 [cross-ref]
Pudney J., Oneta M., Mayer K., Seage G., Anderson D. Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1 Lancet 1992 ;  340 : 1470 [cross-ref]
Diekman A.B., Herr J.C. Sperm antigens and their use in the development of an immunocontraceptive Am. J. Reprod. Immunol. 1997 ;  37 : 111-117 [cross-ref]
Adoyo P.A., Moore A., Moore H.D. A strategy for identifying candidate sperm antigens for immunocontraception: isolation of human testis cDNA clones using polyclonal antisera directed against hamster acrosomal membrane preparation Int. J. Androl. 1995 ;  18 : 32-38 [cross-ref]
Naz R.K., Chauhan S.C. Presence of antibodies to sperm YLP(12) synthetic peptide in sera and seminal plasma of immunoinfertile men Mol. Hum. Reprod. 2001 ;  7 : 21-26 [cross-ref]
Delves P.J. How far from a hormone-based contraceptive vaccine ? J. Reprod. Immunol. 2004 ;  62 : 69-78 [cross-ref]
Primakoff P., Lathrop W., Woolman L., Cowan A., Myles D. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20 Nature 1988 ;  335 : 543-546 [cross-ref]
Primakoff P., Woolman-Gamer L., Tung K.S., Myles D.G. Reversible contraceptive effect of PH-20 immunization in male guinea pigs Biol. Reprod. 1997 ;  56 : 1142-1146 [cross-ref]
O’rand M.G., Widgren E.E., Sivashanmugam P., Richardson R.T., Hall S.H., French F.S., Vandevoort C.A., Ramachandra S.G., Ramesh V., Jagannadha Rao A. Reversible immunocontraception in male monkeys immunized with eppin Science 2004 ;  306 : 1189-1190
O’rand M.G., Widgren E.E., Wang Z., Richardson R.T. Eppin: an effective target for male contraception Mol. Cell. Endocrinol. 2006 ;  250 : 157-162
Goldberg E., Vandeberg J.L., Mahony M.C., Doncel G.F. Immune response of male baboons to testis-specific LDH-C(4) Contraception 2001 ;  64 : 93-98 [cross-ref]
Moudgal N.R., Jeyakumar M., Krishnamurthy H.N., Sridhar S., Krishnamurthy H., Martin F. Development of male contraceptive vaccine--a perspective Hum. Reprod. Update 1997 ;  3 : 335-346 [cross-ref]
Vanage G.R., Mehta P.B., Moodbidri S.B., Iyer K.S. Effect of immunization with synthetic peptide corresponding to region 1-17 of human seminal plasma inhibin on fertility of male rats Arch. Androl. 2000 ;  44 : 11-21
Hamamah S., Royere D., Jean M., Lucas H., Barthelemy C., Barriere P., Lansac J. Le futur de la contraception masculine: Immunocontraception par la prévention de l’interaction gamétique Contracept. Fertil. Sex. 1997 ;  25 : 136-140
Garg S., Talwar G.P., Upadhyay S.N. Immunocontraceptive activity guided fractionation and characterization of active constituents of neem (Azadirachta indica) seed extracts J. Ethnopharmacol. 1998 ;  60 : 235-246 [cross-ref]
Upadhyay S.N., Dhawan S., Garg S., Talwar G.P. Immunomodulatory effects of neem (Azadirachta indica) oil Int. J. Immunopharmacol. 1992 ;  14 : 1187-1193 [cross-ref]
Bardhan J., Riar S.S., Sawhney R.C., Kain A.K., Thomas P., Ilavazhagan G. Neem oil--a fertility controlling agent in rhesus monkey Indian J. Physiol. Pharmacol. 1991 ;  35 : 278-280
Riar S., Devakumar C., Ilavazhagan G., Bardhan J., Kain A.K., Thomas P., Singh R., Singh B. Volatile fraction of neem oil as a spermicide Contraception 1990 ;  42 : 479-487 [cross-ref]
Mushtaq M., Kulp S., Chang W., Lin Y.C. Gossypol inhibits human chorionic gonadotropin-stimulated testosterone production by cultured canine testicular interstitial cells Res. Commun. Mol. Pathol. Pharmacol. 1996 ;  91 : 259-272
Zhang G.Y., Xiao B., Chen Z.W., Zhu J.C., Meng G.D. Dynamic study of serum gonadotrophin and testosterone levels in gossypol-treated men. Long term follow-up study of 60 cases Int. J. Androl. 1985 ;  8 : 177-185
Coutinho E.M., Melo J.F., Barbosa I., Segal S.J. Antispermatogenic action of gossypol in men Fertil. Steril. 1984 ;  42 : 424-430
Hong C.Y., Huang J.J., Wu P. The inhibitory effect of gossypol on human sperm motility: relationship with time, température and concentration Hum. Toxicol. 1989 ;  8 : 49-51 [cross-ref]
Zavos P.M., Zarmakoupis-Zavos P.N. The inhibitory effects of gossypol on human sperm motility characteristics possible modes of reversibility of those effects Tohoku J. Exp. Med. 1996 ;  179 : 167-175 [cross-ref]
Waites G.M., Wang C., Griffin P.D. Gossypol: reasons for its failure to be accepted as a safe, reversible maie antifertility drug Int. J. Androl. 1998 ;  21 : 8-12
Yu Z.H., Chan H.C. Gossypol as a maie antifertility agent--why studies should have been continued Int. J. Androl. 1998 ;  21 : 2-7 [cross-ref]
Coutinho E.M., Athayde C., Atta G., Gu Z.P., Chen Z.W., Sang G.W., Emuveyan E., Adekunle A.O., Mati J., Otubu J., Reidenberg M.M., Segal S.J. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study Contraception 2000 ;  61 : 61-67 [cross-ref]
Van Der Spoel A.C., Jeyakumar M., Butters T.D., Charlton H.M., Moore H.D., Dwek R.A., Platt F.M. Reversible infertility in male mice after oral administration of alkylated imino sugars : a nonhormonal approach to male contraception Proc. Natl. Acad. Sci. USA 2002 ;  99 : 17173-17178 [cross-ref]
Walden C.M., Butters T.D., Dwek R.A., Platt F.M., Van Der Spoel A.C. Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin Hum. Reprod 2006 ;  21 : 1309-1315 [cross-ref]
Cheng C.Y., Mruk D., Silvestrini B., Bonanomi M., Wong C.H., Siu M.K., Lee N.P., Lui W.Y., Mo M.Y. AF-2364 [l-(2, 4- dichlorobenzyl)-lH-indazole-3-carbohydrazide] is a potential male contraceptive a review of recent data Contraception 2005 ;  72 : 251-261 [cross-ref]
Siu M.K., Wong C.H., Lee W.M., Cheng C.Y. Sertoli-germ cell anchoring junction dynamics in the testis are regulated by an interplay of lipid and protein kinases J. Biol. Chem. 2005 ;  280 : 25029-25047 [cross-ref]
Hild S.A., Attardi B.J., Reel J.R. The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone Biol. Reprod. 2004 ;  71 : 348-358 [cross-ref]
Hild S.A., Meistrich M.L., Blye R.P., Reel J.R. Lupron depot prevention of antispermatogenic/antifertility activity of the indenopyridine, CDB-4022, in the rat Biol. Reprod. 2001 ;  65 : 165-172
Hild S.A., Reel J.R., Larner J.M., Blye R.P. Disruption of spermatogenesis and Sertoli cell structure and fonction by the indenopyridine CDB-4022 in rats Biol. Reprod. 2001 ;  65 : 1771-1779
Carlson A.E., Westenbroek R.E., Quill T., Ren D., Clapham D.E., Hille B., Garbers D.L., Babcock D.F. CatSperl required for evoked Ca2+ entry and control of flagellar fonction in sperm Proc. Natl. Acad. Sci. USA 2003 ;  100 : 14864-14868 [cross-ref]
Barfield J.P., Yeung C.H., Cooper T.G. Characterization of potassium channels involved in volume régulation of human spermatozoa Mol. Hum. Reprod. 2005 ;  11 : 891-897
Da Silva N., Silberstein C., Beaulieu V., Pietrement C., Van Hoek A.N., Brown D., Breton S. Postnatal expression of aquaporins in epithelial cells of the rat epididymis Biol. Reprod. 2006 ;  74 : 427-438 [cross-ref]
Pastor-Soler N., Pietrement C., Breton S. Role of acid/base transporters in the male reproductive tract and potential consequences of their malfunction Physiology (Bethesda) 2005 ;  20 : 417-428 [cross-ref]
Quill T.A., Wang D., Garbers D.L. Insights into sperm cell motility signaling through sNHE and the CatSpers Mol. Cell. Endocrinol. 2006 ;  250 : 84-92 [cross-ref]
Livera G., Xie F., Garcia M.A., Jaiswal B., Chen J., Law E., Storm D.R., Conti M. Inactivation of the mouse adenylyl cyclase 3 gene disrupts male fertility and spermatozoon function Mol. Endocrinol. 2005 ;  19 : 1277-1290 [cross-ref]
Miki K., Qu W., Goulding E.H., Willis W.D., Bunch D.O., Strader L.F., Perreault S.D., Eddy E.M., O’brien D.A. Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility Proc. Natl. Acad. Sci. USA 2004 ;  101 : 16501-16506 [cross-ref]
Vasta V., Sonnenburg W.K., Yan C., Soderling S.H., Shimizu-Albergine M., Beavo J.A. Identification of a new variant of PDE1A calmodulin-stimulated cyclic nucleotide phosphodiesterase expressed in mouse sperm Biol. Reprod. 2005 ;  73 : 598-609 [cross-ref]
Fukudam N., Akama T.O. The role of N-glycans in spermatogenesis Cytogenet. Genome Res. 2003 ;  103 : 302-306
Fukuda M.N., Akama T.O. The in vivo rôle of alpha-mannosidase IIx and its role in processing of N-glycans in spermatogenesis Cell. Mol. Life Sci. 2003 ;  60 : 1351-1355 [cross-ref]
Akama T.O., Nakagawa H., Sugihara K., Narisawa S., Ohyama C., Nishimura S., O’brien D.A., Moremen K.W., Millan J.L., Fukuda M.N. Germ cell survival through carbohydrate-mediated interaction with Sertoli cells Science 2002 ;  295 : 124-127 [cross-ref]
Spehr M., Hatt H. A potential role of odorant receptor agonists and antagonists in the treatment of infertility and contraception Curr. Opin. Investig. Drugs 2005 ;  6 : 364-368
Spehr M., Schwane K., Riffell J.A., Zimmer R.K., Hatt H. Odorant receptors and olfactory-like signaling mechanisms in mammalian sperm Mol. Cell Endocrinol. 2006 ;  250 : 128-136 [cross-ref]
Stein K.K., Go J.C., Primakoff P., Myles D.G. Defects in secretory pathway trafficking during sperm development in Adam2 knockout mice Biol. Reprod. 2005 ;  73 : 1032-1038 [cross-ref]
Nolan M.A., Babcock D.F., Wennemuth G., Brown W., Burton K.A., McKnight G.S. Sperm-specific protein kinase A catalytic subunit Calpha2 orchestrates cAMP signaling for maie fertility Proc. Natl. Acad. Sci. USA 2004 ;  101 : 13483-13488 [cross-ref]
Heinemann K., Saad F., Wiesemes M., White S., Heinemann L. Attitudes toward maie fertility control. results of a multinational survey on four continents Hum. Reprod. 2005 ;  20 : 549-556

© 2007 
Elsevier Masson SAS. Tous droits réservés.